Home > Category > Signaling Pathways > Protein Tyrosine Kinase/RTK > Bcr-Abl > Olverembatinib (GZD824; HQP1351)

Olverembatinib (GZD824; HQP1351)

ChemLeader 98+%
Catalog No:CL2492 CAS No.:1257628-77-5 MDLNo: Formula:C29H27F3N6O MW:532.56
Size Availability Price(USD) VIP Price (USD) Quantity
10 mg 3-5days $125.00 Visible after login
- +
25 mg 3-5days $245.00 Visible after login
- +
50 mg 3-5days $365.00 Visible after login
- +

Chemical safety data sheet(MSDS)

Download MSDS
  • Product Overview
  • Related documents
  • Product details
  • Related literature
Product Overview
Product Name Olverembatinib (GZD824; HQP1351)
CAS1257628-77-5
FormulaC29H27F3N6O
MW532.56
AppearanceOff-white to yellow powder
Storage condition Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Product details

GZD824 potently suppressed proliferation of Bcr-Abl-positive K562 and Ku812 human CML cells with IC(50) values of 0.2 and 0.13 nM, respectively. It also displayed good oral bioavailability (48.7%), a reasonable half-life (10.6 h), and promising in vivo antitumor efficacy.

GZD824 induced tumor regression in mouse xenograft tumor models driven by Bcr-Abl(WT) or the mutants and significantly improved the survival of mice bearing an allograft leukemia model with Ba/F3 cells harboring Bcr-Abl(T315I).


Related literature
Sorry, there is no relevant literature
Related
Sorry, no related items
Service
ChemLeader
021-58180488
Online service time: 9:00-18:00 on weekdays